Phase II study of eribulin mesylate in patients (pts) with advanced soft tissue sarcoma (STS).

被引：2
|
作者：
Naito, Yoichi
Kawai, Akira
Araki, Nobuhito
Ozaki, Toshifumi
Sugiura, Hideshi
Yazawa, Yasuo
Morioka, Hideo
Matsumine, Akihiko
Hiraiwa, Masahide
Asami, Shun
Isu, Kazuo
机构：
[1] Natl Canc Ctr Hosp East, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan
[4] Okayama Univ Hosp, Okayama, Japan
[5] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[6] Saitama Med Univ, Int Med Ctr, Saitama, Japan
[7] Keio Univ, Tokyo, Japan
[8] Mie Univ, Grad Sch Med, Tsu, Mie, Japan
[9] Eisai, Tokyo, Japan
[10] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.10567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10567
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of oral ENMD-2076 administered to patients (pts) with advanced soft tissue sarcoma (STS).
    Loong, Herbert H. F.
    Blackstein, Martin E.
    Gupta, Abha A.
    Hogg, David
    Mackay, Helen
    Dhani, Neesha C.
    Oza, Amit M.
    Moore, Malcolm J.
    Razak, Albiruni R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Phase II study of oral ENMD-2076 administered to patients (pts) with advanced soft tissue sarcoma (STS).
    Loong, Herbert H. F.
    Blackstein, Martin E.
    Gupta, Abha A.
    Hogg, David
    Culala, Lindsay
    Nyquist-Schultz, Kjirsten
    Baker, Stephanie
    Wang, Lisa
    Razak, Albiruni R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Safety and efficacy of eribulin mesylate in patients with advanced soft tissue sarcoma in daily practice
    Inagaki, C.
    Shimoi, T.
    Okuma, H. S.
    Kawachi, A.
    Shimomura, A.
    Noguchi, E.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Phase II study of eribulin and pembrolizumab in patients (pts) with metastatic soft tissue sarcomas (STS): Report of LMS cohort.
    Nathenson, Michael
    Choy, Edwin
    Carr, Neena D.
    Hibbard, Hayley D.
    Mazzola, Emanuele
    Catalano, Paul J.
    Thornton, Katherine Anne
    Morgan, Jeffrey A.
    Cote, Gregory Michael
    Merriam, Priscilla
    Wagner, Andrew J.
    Demetri, George D.
    George, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)
    Zachary Veitch
    Alona Zer
    Herbert Loong
    Samer Salah
    Maryam Masood
    Abha Gupta
    Penelope A. Bradbury
    David Hogg
    Andrew Wong
    Rita Kandel
    George S. Charames
    Albiruni R. Abdul Razak
    Scientific Reports, 9
  • [6] A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS)
    Veitch, Zachary
    Zer, Alona
    Loong, Herbert
    Salah, Samer
    Masood, Maryam
    Gupta, Abha
    Bradbury, Penelope A.
    Hogg, David
    Wong, Andrew
    Kandel, Rita
    Charames, George S.
    Razak, Albiruni R. Abdul
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Phase I/II study of docetaxel (D), gemcitabine (G), and bevacizumab (B) in patients (pts) with advanced or recurrent soft tissue sarcoma (STS)
    Verschraegen, C. F.
    Fekrazad, H. M.
    Rabinowitz, I.
    Quinn, R.
    Snyder, D.
    Judson, P.
    Purdy, M.
    Lee, F. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Phase I/II study of docetaxel (D), gemcitabine (G), and bevacizumab (B) in patients (pts) with advanced or recurrent soft tissue sarcoma (STS)
    Verschraegen, C. F.
    Quinn, R.
    Rabinowitz, I.
    Arias-Pulido, H.
    Muller, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma
    Kawai, Akira
    Araki, Nobuhito
    Naito, Yoichi
    Ozaki, Toshifumi
    Sugiura, Hideshi
    Yazawa, Yasuo
    Morioka, Hideo
    Matsumine, Akihiko
    Saito, Kenichi
    Asami, Shun
    Isu, Kazuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (02) : 137 - 144
  • [10] Treatment results in elderly patients (pts) diagnosed with locally advanced soft tissue sarcoma (STS)
    Paterczyk, H. M. Kosela
    Teterycz, P.
    Kozak, K.
    Klimczak, A.
    Switaj, T.
    Rogala, P.
    Jagodzinska-Mucha, P.
    Sobczuk, M. Polaczek P.
    Mariuk-Jarema, A.
    Kopec, S.
    Placzke, J.
    Dudzisz-Sledz, M. E.
    Ostaszewski, K.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S1115 - S1115
12345